AC
IMNN icon

Armistice Capital’s Imunon IMNN Stock Holding History

Armistice Capital’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258K Sell
144,767
-203,563
-58% -$502K ﹤0.01% 262
2026
Q1 		$1.02M Buy
348,330
+81,444
+31% +$268K 0.02% 164
2025
Q4 		$1.02M Buy
+266,886
New +$1.14M 0.01% 175

Other funds holding IMNN

RCA
Riverview Capital Advisers Boston, Massachusetts $349M AUM 33.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Armistice Capital's IMNN Position: Q2 2026 in Review

Armistice Capital reduced its Imunon (IMNN) stake by 58% in Q2 2026, selling an estimated $502K and leaving 144,767 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #262.

Armistice Capital first reported a position in IMNN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.02M in Q1 2026. 23 funds tracked by Wall St. Rank hold IMNN as of Q2 2026.

  • Armistice Capital held 144,767 shares of Imunon worth $258K as of Q2 2026.
  • Armistice Capital sold 203,563 Imunon shares in Q2 2026, an estimated $502K.
  • Imunon made up ﹤0.01% of Armistice Capital's portfolio in Q2 2026, its #262 holding.
  • Armistice Capital first reported a position in Imunon in Q4 2025 and has held it in 3 quarters since.
  • Armistice Capital's Imunon position peaked at $1.02M in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.